Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Yonemoto
L. Yonemoto
Medicine
Internal medicine
Oncology
Rapamycin Analog
Pathology
4
Papers
91
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
317 Safety and efficacy results from a phase 1 dose-escalation trial of the parp inhibitor talazoparib (bmn-673) in combination with either temozolomide or irinotecan in patients with advanced malignancies
2015
European Journal of Cancer
Zev A. Wainberg
J.R. Hecht
Gottfried E. Konecny
Bartosz Chmielowski
Richard S. Finn
Diego Martinez
L. Yonemoto
John A. Glaspy
Dennis J. Slamon
Show All
Source
Cite
Save
Citations (3)
Deforolimus trial 106- A Phase I trial evaluating 7 regimens of oral Deforolimus (AP23573, MK-8669)
2008
Journal of Clinical Oncology
Monica M. Mita
Carolyn D. Britten
E. Poplin
W. D. Tap
A. Carmona
L. Yonemoto
D. S. Wages
Camille L. Bedrosian
Eric H. Rubin
Anthony W. Tolcher
Show All
Source
Cite
Save
Citations (53)
Pharmacokinetics of oral deforolimus (AP23573, MK-8669)
2008
Journal of Clinical Oncology
Gerald J. Fetterly
Monica M. Mita
Carolyn D. Britten
E. Poplin
W. D. Tap
A. Carmona
L. Yonemoto
Camille L. Bedrosian
Eric H. Rubin
Anthony W. Tolcher
Show All
Source
Cite
Save
Citations (20)
A pilot study of IV bevacizumab in hepatocellular cancer patients undergoing chemoembolization
2005
Journal of Clinical Oncology
Carolyn D. Britten
Richard S. Finn
Antoinette S. Gomes
Rafael G. Amado
L. Yonemoto
G. Bentley
R. Mass
Ronald W. Busuttil
D. Slamon
Show All
Source
Cite
Save
Citations (15)
1